Back to List View Graph View

Camptothecin

Camptothecin (CPT) is a cytotoxic quinoline alkaloid of the monoterpene indole class, first isolated from the bark and wood of Camptotheca acuminata, a tree native to southern China.

Where the papers sit

14 papers from the last 6 months study camptothecin directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 1 human data · 13 preclinical

Themes one subject

Those 14 are all about one subject.

  • Targeted Cancer Drug Delivery

    Targeted cancer drug delivery is moving toward multifunctional systems that combine tumor recognition with controlled release. Polymeric, dendrimer, supramolecular, and self-assembling platforms use pH, redox, light, HOCl, or sonodynamic triggers, sometimes directing treatment to mitochondria. Co-delivery with siSTAT3, cabazitaxel, niraparib, or photodynamic therapy seeks stronger killing and may address p53 mutation-mediated resistance and ferroptosis. Fluorescence or chemiluminescence reporting is increasingly paired with release, but efficacy and systemic toxicity remain key translational tests.

    14 papers

camptothecin chemical structure

Papers

The 14 papers from the last 6 months that study camptothecin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Targeted Cancer Drug Delivery (14)
  1. Biotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde. Biomacromolecules · 9 Nov 2026 PMID 43002022
  2. Superior Therapeutic Efficacy and Reduced Systemic Toxicity of a Cucurbit[7]uril-Camptothecin Supramolecular Complex in Colorectal Cancer. Molecular pharmaceutics · 2 Nov 2026 PMID 42969715
  3. Click-crosslinked arginine-based nanoplatform for co-delivery of camptothecin and siSTAT3 for metastatic breast cancer therapy. International journal of pharmaceutics · 4 Sept 2026 PMID 42697388
  4. Sanger's Reagent-Mediated Prodrug for Light-Controlled Release of Camptothecin With Fluorescent Indication. Chembiochem : a European journal of chemical biology · 28 Aug 2026 PMID 42661320
  5. Discovery of novel hydroxycamptothecin derivatives as potent Topo I inhibitors for antitumor guided by molecular dynamics. European journal of medicinal chemistry · 24 Jul 2026 PMID 42497470
  6. Cabazitaxel and camptothecin co-loaded in pH-sensitive transferrin-targeted, PEGylated cholesterol-based poly(amidoamine) dendrimers as a synergistic combination for prostate cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 22 Jul 2026 PMID 42486016
  7. Selenide-Bridged Redox-Responsive Nanoparticles: A Synergistic Strategy to Overcome p53 Mutation-Mediated Drug Resistance in Gastric Cancer. ACS nano · 21 Jul 2026 PMID 42478957
  8. A phospholipid Camptothecin-Niraparib conjugate self-assembled into supramolecular nanotubes for combination cancer therapy. Journal of controlled release : official journal of the Controlled Release Society · 15 Jul 2026 PMID 42456976
  9. Hyaluronic acid-modified nanoparticles for chemo/sonodynamic therapy: Maximizing antitumor efficacy through the induction of ferroptosis and apoptosis. International journal of biological macromolecules · 5 Jul 2026 PMID 42402299
  10. Tumor-targeted activatable molecular agent for synergistic chemo-photodynamic therapy. Bioorganic chemistry · 3 Jul 2026 PMID 42398394
  11. Rational design of active pharmaceutical ingredient-based co-assembled nanoparticles for cancer immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 21 Jun 2026 PMID 42324030
  12. Light-programmable, high-drug-loading nanomedicine based on dimeric camptothecin. Biomaterials science · 17 Jun 2026 PMID 42304791
  13. An HOCl-Activated Acyl Hydrazide Platform for Fluorescence-Guided Release of Hydroxyl-Containing Drugs. Analytical chemistry · 1 Jun 2026 PMID 42224648
  14. An HOCl-activated chemiluminescent prodrug enabling self-reporting camptothecin release and imaging-guided therapy in peritoneal metastasis. Bioorganic & medicinal chemistry · 29 May 2026 PMID 42214293

By study type

Human data, design not indexed (1)
  1. Biotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde. Biomacromolecules · 9 Nov 2026 PMID 43002022
Preclinical: animal, cell and lab studies (13)
  1. Superior Therapeutic Efficacy and Reduced Systemic Toxicity of a Cucurbit[7]uril-Camptothecin Supramolecular Complex in Colorectal Cancer. Molecular pharmaceutics · 2 Nov 2026 PMID 42969715
  2. Click-crosslinked arginine-based nanoplatform for co-delivery of camptothecin and siSTAT3 for metastatic breast cancer therapy. International journal of pharmaceutics · 4 Sept 2026 PMID 42697388
  3. Sanger's Reagent-Mediated Prodrug for Light-Controlled Release of Camptothecin With Fluorescent Indication. Chembiochem : a European journal of chemical biology · 28 Aug 2026 PMID 42661320
  4. Discovery of novel hydroxycamptothecin derivatives as potent Topo I inhibitors for antitumor guided by molecular dynamics. European journal of medicinal chemistry · 24 Jul 2026 PMID 42497470
  5. Cabazitaxel and camptothecin co-loaded in pH-sensitive transferrin-targeted, PEGylated cholesterol-based poly(amidoamine) dendrimers as a synergistic combination for prostate cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 22 Jul 2026 PMID 42486016
  6. Selenide-Bridged Redox-Responsive Nanoparticles: A Synergistic Strategy to Overcome p53 Mutation-Mediated Drug Resistance in Gastric Cancer. ACS nano · 21 Jul 2026 PMID 42478957
  7. A phospholipid Camptothecin-Niraparib conjugate self-assembled into supramolecular nanotubes for combination cancer therapy. Journal of controlled release : official journal of the Controlled Release Society · 15 Jul 2026 PMID 42456976
  8. Hyaluronic acid-modified nanoparticles for chemo/sonodynamic therapy: Maximizing antitumor efficacy through the induction of ferroptosis and apoptosis. International journal of biological macromolecules · 5 Jul 2026 PMID 42402299
  9. Tumor-targeted activatable molecular agent for synergistic chemo-photodynamic therapy. Bioorganic chemistry · 3 Jul 2026 PMID 42398394
  10. Rational design of active pharmaceutical ingredient-based co-assembled nanoparticles for cancer immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 21 Jun 2026 PMID 42324030
  11. Light-programmable, high-drug-loading nanomedicine based on dimeric camptothecin. Biomaterials science · 17 Jun 2026 PMID 42304791
  12. An HOCl-Activated Acyl Hydrazide Platform for Fluorescence-Guided Release of Hydroxyl-Containing Drugs. Analytical chemistry · 1 Jun 2026 PMID 42224648
  13. An HOCl-activated chemiluminescent prodrug enabling self-reporting camptothecin release and imaging-guided therapy in peritoneal metastasis. Bioorganic & medicinal chemistry · 29 May 2026 PMID 42214293